Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
3.640
-0.160 (-4.21%)
At close: Dec 27, 2024, 4:00 PM
3.710
+0.070 (1.92%)
After-hours: Dec 27, 2024, 4:23 PM EST

Achieve Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Selling, General & Admin
13.6311.4410.729.137.876.85
Upgrade
Research & Development
17.6415.8130.0823.976.889.67
Upgrade
Operating Expenses
31.2727.2540.833.0914.7516.53
Upgrade
Operating Income
-31.27-27.25-40.8-33.09-14.75-16.53
Upgrade
Interest Expense
-2.77-2.85-1.79---
Upgrade
Interest & Investment Income
2.080.830.20.020.070.17
Upgrade
Other Non Operating Income (Expenses)
-0.01-0.010.04-0.08-0.05-0.04
Upgrade
EBT Excluding Unusual Items
-31.96-29.29-42.35-33.15-14.73-16.4
Upgrade
Other Unusual Items
-0.98-0.53----
Upgrade
Pretax Income
-32.94-29.82-42.35-33.15-14.73-16.4
Upgrade
Net Income
-32.94-29.82-42.35-33.15-14.73-16.4
Upgrade
Net Income to Common
-32.94-29.82-42.35-33.15-14.73-16.4
Upgrade
Shares Outstanding (Basic)
292011830
Upgrade
Shares Outstanding (Diluted)
292011830
Upgrade
Shares Change (YoY)
60.31%87.17%30.46%198.64%559.42%134.93%
Upgrade
EPS (Basic)
-1.15-1.50-4.00-4.08-5.42-39.76
Upgrade
EPS (Diluted)
-1.15-1.50-4.00-4.08-5.42-39.76
Upgrade
Free Cash Flow
-24.95-24.5-37.57-29.44-13.49-15.27
Upgrade
Free Cash Flow Per Share
-0.87-1.24-3.55-3.63-4.96-37.03
Upgrade
EBITDA
-31.04-27.02-40.56-32.84-14.5-16.27
Upgrade
D&A For EBITDA
0.230.230.240.250.260.25
Upgrade
EBIT
-31.27-27.25-40.8-33.09-14.75-16.53
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.